Table 1.
Characteristics of the RCTs included for the meta-analysis.
| Mean age | No. of patients | Intervention strategy | |||||||
| First author | Year of publication | Treatment group | Control group | Treatment group | Control group | Diagnostic criteria∗ | Treatment group | Control group | Duration |
| Xiao-Xia Cheng[17] | 2001 | 34.27 ± 11.64 | 33.33 ± 11.05 | 30 | 15 | A, B, E | Control + yishen tongluo decoction (6 Chinese herbs) | Pred, T1, CTX, ACEI | 16 weeks |
| Xing-Cai He[18] | 2007 | 42.73 ± 3.22 | 43.33 ± 3.45 | 50 | 50 | A, B, C, E | Control + qingxue xiaobai decoction (12 Chinese herbs) | Pred, CTX | 12 weeks |
| Cai-Feng Zhu[19] | 2007 | 32.00 | 34.68 | 35 | 31 | A, B | Control + (13 Chinese herbs) | ACEI/ARB + Fish oil + therapy for disease | 24 weeks |
| Wen-Gang Guo[20] | 2014 | 37.1 | 36.2 | 20 | 15 | A, B, C, E | Control + (9 Chinese herbs) | Pred, CTX | 24 weeks |
| Hai-Yan Lv[21] | 2016 | 43.1 ± 3.0 | 42.1 ± 3.4 | 50 | 50 | A, B, D, E | Control + self-designed peishen decoction (14 Chinese herbs) | GC+FK506 | 6 weeks |
| Zhi-Jie Dang[22] | 2017 | 34.1 ± 1.2 | 35.3 ± 0.9 | 45 | 45 | A, B, C, E | Control + (10 Chinese herbs) | Pred, CTX | 24 weeks |
| Xu-dan Heng[23] | 2017 | 42.1 ± 7.4 | 43.1 ± 6.7 | 42 | 42 | A, B, D, E | Control + peishen decoction (9 Chinese herbs) | Hormones+FK506 | 48 weeks |
| Hui Feng[24] | 2014 | - | - | 30 | 30 | A, B, E | Control + (10 Chinese herbs) | Hormones + stomach protection + calcium supplement | 12 weeks |
| Xin-wei Wang[25] | 2010 | 52.25 | 50.5 | 22 | 20 | A, B, C, E | Control + shenzong huoxue decoction (14 Chinese herbs) | Anticoagulant + lipid-lowering + immunosuppressant | 12 weeks |
| Xiao-hua Yan[26] | 2013 | 38.07 ± 11.03 | 34.17 ± 8.99 | 30 | 30 | A, B, E | Control + pishen tongluo decoction (9 Chinese herbs) | ACEI | 8 weeks |
| Jiang Hai[27] | 2015 | 39.26 ± 3.14 | 40.28 ± 3.16 | 45 | 45 | A, B, C, E | Control + shenzong huoxue decoction (12 Chinese herbs) | Anticoagulant + lipid-lowering + immunosuppressant + hormone | 48 weeks |
| Yan Liu[28] | 2012 | − | − | 30 | 30 | A, B, C, E | Control + yiqi tongluo decoction (8 Chinese herbs) | ACEI/ARB +Anticoagulant + lipid-lowering | 8 weeks |
| Qing-zhen Liu[29] | 2016 | 56.4 ± 7.8 | 55.6 ± 8.3 | 30 | 30 | A, B, E | Control +yiqi tongluo decoction (11 Chinese herbs) | Hormones+FK506 | 12 weeks |
| Qiong-li Yin[30] | 2017 | 49.61 ± 3.11 | 49.06 ± 3.09 | 50 | 50 | A, B, E | Control +qingshen jiedu decoction (10 Chinese herbs) | ACEI | 12 weeks |
| Qiu-xia Wu[31] | 2009 | − | − | 15 | 15 | A, B, E | Control +zhengqing fengtongning decoction | Hormones +ACEI +CTX | 36 weeks |
| Jia-liang Guan[32] | 2009 | 33.67 ± 9.94 | 32.72 ± 10.21 | 30 | 30 | A, B, E | Control +jiedu fushen tongyu decoction (13 Chinese herbs) | Pred | 8 weeks |